Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women

Journal of Bone and Mineral Research

Volumn 29, Issue 2, 2014, Pages 380-388

  Bala, Yohann ^a   Chapurlat, Roland ^b   Cheung, Angela M ^c   Felsenberg, Dieter ^d   Laroche, Michel ^e   Morris, Edward ^f   Reeve, Jonathan ^g   Thomas, Thierry ^h   Zanchetta, Jose ⁱ   Bock, Oliver ^d   Ghasem Zadeh, Ali ^a   Djoumessi, Roger Martin Zebaze ^a   Seeman, Ego ^a   Rizzoli, René ^j  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INSERM   (France)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e CHU PURPAN   (France)

^f NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^g NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^h UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

ⁱ Instituto de Investigaciones Metabolicas   (Argentina)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

BISPHOSPHONATES; BONE REMODELING; CORTICAL POROSITY; HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; MENOPAUSE; MICROARCHITECTURE

Indexed keywords

AMINO TERMINAL PROPEPTIDE TYPE 1 PROCOLLAGEN; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; PLACEBO; PROCOLLAGEN; RISEDRONIC ACID; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DATA ANALYSIS SOFTWARE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OSTEOPENIA; POROSITY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIUS; RANDOMIZED CONTROLLED TRIAL; TIBIA; TRABECULAR BONE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

BISPHOSPHONATES; BONE REMODELING; CORTICAL POROSITY; HIGH-RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; MENOPAUSE; MICROARCHITECTURE;

ADULT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; ETIDRONIC ACID; FEMALE; HUMANS; MIDDLE AGED; PEPTIDES; POSTMENOPAUSE; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892690845     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2101     Document Type: Article

References (37)

1. Frost HM,. Bone dynamics in metabolic bone disease. J Bone Joint Surg Am. 1966; 48: 1192-203.
2. Jaworski ZF,. Coupling of bone formation to bone resorption: a broader view. Calcif Tissue Int. 1984; 36: 531-5.
3. Akkus O, Polyakova-Akkus A, Adar F, Schaffler MB,. Aging of microstructural compartments in human compact bone. J Bone Miner Res. 2003; 18: 1012-9.
4. Bala Y, Farlay D, Delmas PD, Meunier PJ, Boivin G,. Time sequence of secondary mineralization and microhardness in cortical and cancellous bone from ewes. Bone. 2010; 46: 1204-12.
5. Heaney RP,. The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res. 1994; 9: 1515-23.
6. Heaney RP,. The bone remodeling transient: interpreting interventions involving bone-related nutrients. Nutr Rev. 2001; 59: 327-34.
7. Recker R, Lappe J, Davies K, Heaney R,. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res. 2004; 19: 1628-33.
8. Heaney RP, Recker RR, Saville PD,. Menopausal changes in bone remodeling. J Lab Clin Med. 1978; 92: 964-70.
9. Akhter MP, Lappe J, Davies K, Recker R,. Transmenopausal changes in the trabecular bone structure. Bone. 2007; 41: 111-6.
10. Nishiyama KK, Macdonald HM, Buie HR, Hanley DA, Boyd SK,. Postmenopausal women with osteopenia have higher cortical porosity and thinner cortices at the distal radius and tibia than women with normal aBMD: an in vivo HR-pQCT study. J Bone Miner Res. 2010; 25: 882-90.
11. Parfitt AM,. Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biomechanical consequences. Calcif Tissue Int. 1984; 36 (Suppl 1): S123-8.
12. Eriksen EF, Mosekilde L, Melsen F,. Trabecular bone resorption depth decreases with age: differences between normal males and females. Bone. 1985; 6: 141-6.
13. Lips P, Courpron P, Meunier PJ,. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res. 1978; 26: 13-7.
14. Vedi S, Compston JE, Webb A, Tighe JR,. Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Relat Res. 1983; 5: 69-74.
15. Parfitt AM,. Morphologic basis of bone mineral measurements. Transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab. 1980; 4: 273-87.
16. Cohen-Solal ME, Roux C, Valentin-Opran A, Dougados M, Amor B, De Vernejoul MC,. Histomorphometric effect of six month treatment with oral Risedronate in patients with multiple myeloma. Bone. 1993; 14: 505-9.
17. Eriksen EF, Melsen F, Sod E, Barton I, Chines A,. Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone. 2002; 31: 620-5.
18. Boutroy S, Bouxsein ML, Munoz F, Delmas PD,. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005; 90: 6508-15.
19. Zebaze R, Ghasem-Zadeh A, M'bala A, Seeman E,. A new method of segmentation of compact-appearing, transitional and trabecular compartments and quantification of cortical porosity from high resolution peripheral quantitative computed tomographic images. Bone. 2013; 54: 8-20.
20. Wang Q, Wang XF, Iuliano-Burns S, Ghasem-Zadeh A, Zebaze R, Seeman E,. Rapid growth produces transient cortical weakness: a risk factor for metaphyseal fractures during puberty. J Bone Miner Res. 2010; 25: 1521-6.
21. Manolagas SC,. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21: 115-37.
22. Qiu S, Rao DS, Palnitkar S, Parfitt AM,. Dependence of bone yield (volume of bone formed per unit of cement surface area) on resorption cavity size during osteonal remodeling in human rib: implications for osteoblast function and the pathogenesis of age-related bone loss. J Bone Miner Res. 2010; 25: 423-30.
23. Seeman E, Delmas PD,. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med. 2006; 354: 2250-61.
24. Parfitt AM,. Osteoporosis: 50 years of change, mostly in the right direction. In:, Compston J, Ralston SH, editors Osteoporosis and bone biology: the state of the art. London: International Medical Press; p. 1-13. 2000.
25. van der Linden JC, Homminga J, Verhaar JA, Weinans H,. Mechanical consequences of bone loss in cancellous bone. J Bone Miner Res. 2001; 16: 457-65.
26. Hernandez CJ, Gupta A, Keaveny TM,. A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. J Bone Miner Res. 2006; 21: 1248-55.
27. Zebaze RM, Ghasem-Zadeh A, Bohte A, et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010; 375: 1729-36.
28. Bjornerem A, Ghasem-Zadeh A, Bui M, et al. Remodeling markers are associated with larger intracortical surface area but smaller trabecular surface area: a twin study. Bone. 2011; 49: 1125-30.
29. Borah B, Dufresne T, Nurre J, et al. Risedronate reduces intracortical porosity in women with osteoporosis. J Bone Miner Res. 2010; 25: 41-7.
30. Schaffler MB, Burr DB,. Stiffness of compact bone: effects of porosity and density. J Biomech. 1988; 21: 13-6.
31. Burr DB,. Cortical bone: a target for fracture prevention ? Lancet. 2010; 375: 1672-3.
32. Currey JD,. Bones: structure and mechanics. Princeton, NJ: Princeton University Press; 2006.
33. Russell RG, Watts NB, Ebetino FH, Rogers MJ,. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008; 19: 733-59.
34. Roelofs AJ, Stewart CA, Sun S, et al. Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo. J Bone Miner Res. 2012; 27: 835-47.
35. Boyce RW, Paddock CL, Gleason JR, Sletsema WK, Eriksen EF,. The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site. J Bone Miner Res. 1995; 10: 211-21.
36. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral,nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999; 282: 1344-52.
37. Harrington JT, Ste-Marie LG, Brandi ML, et al. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int. 2004; 74: 129-35.